Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selumetinib in paediatric patients with BRAF-aberrant or ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
0
Authors
Jason Fangusaro
33 more
Jason Fangusaro
•
Arzu Onar‐Thomas
31 more
•
Maryam Fouladi
Published
May 28, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Cancer Oncology
Medicine
Pathology
Internal Medicine
Show all topics
DOI
10.1016/s1470-2045(19)30277-3
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Physics
Cancer Oncology
Medicine
Pathology
Internal Medicine
Show all topics
DOI
10.1016/s1470-2045(19)30277-3
License
publisher-specific-oa
